BackEvolent Health Overview
Evolent Health Inc - Ordinary Shares - Class A

Evolent Health Target Price

See Evolent Health's analyst price targets ($7) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.8

Average Target Price

$7.0045.8% upside

1 analysts in the last 4 months

High: $7 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-21Canaccord Genuity$745.8% upsideOpen
2026-06-30Truist Financial$745.8% upsideOpen
2026-05-12Canaccord Genuity$625% upsideOpen
2026-02-25Truist Financial$625% upsideOpen
2026-02-25BMO CapitalSean Dodge$3.527.1% downsideOpen
2026-02-02BTIGDavid Larsen$10108.3% upsideOpen
2025-12-02Piper Sandler$625% upsideOpen
2025-01-16UBSKevin Caliendo$14191.7% upsideOpen
2025-01-15Truist FinancialJailendra Singh$20316.7% upsideOpen
2025-01-14RBC CapitalSean Dodge$17254.2% upsideOpen
2025-01-10JMP SecuritiesConstantine Davides$18275% upsideOpen
2024-11-18OppenheimerMohan Naidu$28483.3% upsideOpen
2024-10-17StephensJeff Garro$38691.7% upsideOpen
2024-08-09Truist FinancialJailendra Singh$33587.5% upsideOpen
2024-06-05RBC CapitalSean Dodge$42775% upsideOpen
2024-05-14Truist FinancialJailendra Singh$28483.3% upsideOpen
2024-04-17Piper SandlerJessica Tassan$51962.5% upsideOpen
2024-03-28Canaccord GenuityRichard Close$44816.7% upsideOpen
2022-08-03BTIG$50941.7% upsideOpen
2022-05-09Canaccord Genuity$45837.5% upsideOpen

Evolent Health (EVH) FAQ

The latest target price for EVH is $7. Investors often review this figure alongside Evolent Health's historical trend and sector peers before judging valuation or financial health.

Evolent Health trades near $4.8 while the consensus target sits at $7 (45.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting EVH's target price ($7), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Evolent Health's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.